Working… Menu

Evaluation of Bevacizumab in Combination With First-Line Chemotherapy in Patients Aged 75 Years of Older With Metastatic Colorectal Adenocarcinoma (Prodige20) (Prodige20)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01900717
Recruitment Status : Completed
First Posted : July 16, 2013
Last Update Posted : December 27, 2018
Information provided by (Responsible Party):
Centre Hospitalier Universitaire Dijon